Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC

Go back to Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC
Gilead Sciences (NASDAQ: GILD) Delayed: 145.68 -3.18 (2.14%)
Previous Close $148.86    52 Week High $108.63 
Open $149.47    52 Week Low $71.39 
Day High $149.47    P/E 80.49 
Day Low $144.88    EPS $1.81 
Volume 3,946,913       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 55.19 -1.2 (2.13%)
Previous Close $56.39    52 Week High $35.13 
Open $55.88    52 Week Low $28.10 
Day High $55.89    P/E N/A 
Day Low $55.08    EPS $0.00 
Volume 1,070,581